SUPERNUS PHARMACEUTICALS, INC. Annual Return On Assets in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2022.
  • Supernus Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2023 was 1.69 %, a 25% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Return On Assets for 2022 was 3.61 %, a 6.81% increase from 2021.
  • Supernus Pharmaceuticals, Inc. annual Return On Assets for 2021 was 3.38 %, a 62.1% decline from 2020.
  • Supernus Pharmaceuticals, Inc. annual Return On Assets for 2020 was 8.92 %, a 14.1% decline from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 3.61 +0.23 +6.81% Jan 1, 2022 Dec 31, 2022
2021 3.38 -5.54 -62.1% Jan 1, 2021 Dec 31, 2021
2020 8.92 -1.46 -14.1% Jan 1, 2020 Dec 31, 2020
2019 10.4 -2.03 -16.4% Jan 1, 2019 Dec 31, 2019
2018 12.4 -3.09 -19.9% Jan 1, 2018 Dec 31, 2018
2017 15.5 -20.7 -57.2% Jan 1, 2017 Dec 31, 2017
2016 36.2 +27.6 +321% Jan 1, 2016 Dec 31, 2016
2015 8.6 +18.2 Jan 1, 2015 Dec 31, 2015
2014 -9.62 +73.2 +88.4% Jan 1, 2014 Dec 31, 2014
2013 -82.8 -17.6 -27.1% Jan 1, 2013 Dec 31, 2013
2012 -65.2 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.